Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis

@article{Kotecha2015EfficacyO,
  title={Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis},
  author={D. Kotecha and J. Holmes and H. Krum and D. Altman and on behalf of the Beta-Blockers in Heart Failure Colla Group},
  journal={The Lancet},
  year={2015},
  volume={384},
  pages={2235-2243}
}
BACKGROUND Atrial fibrillation and heart failure often coexist, causing substantial cardiovascular morbidity and mortality. β blockers are indicated in patients with symptomatic heart failure with reduced ejection fraction; however, the efficacy of these drugs in patients with concomitant atrial fibrillation is uncertain. We therefore meta-analysed individual-patient data to assess the efficacy of β blockers in patients with heart failure and sinus rhythm compared with atrial fibrillation… CONTINUE READING
299 Citations

Paper Mentions

Interventional Clinical Trial
Atrial fibrillation is a common heart rhythm disturbance, causing important discomfort for patients, a high risk of stroke, frequent hospital admissions and a two-fold increase in… Expand
ConditionsPermanent Atrial Fibrillation
InterventionDrug
Should β-blockers be used in patients with heart failure and atrial fibrillation?
  • 25
  • Highly Influenced
Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
  • 42
  • PDF
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.
  • 105
  • PDF

References

SHOWING 1-10 OF 52 REFERENCES
Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
  • 101
  • PDF
Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design
  • 27
  • PDF
Risk-treatment mismatch in the pharmacotherapy of heart failure.
  • 225
  • PDF